15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $37M | -$26M | 61.4% | -65.4% | -$24M | $49M | $46M |
| 2024 | $31M | -$19M | 60.9% | -62.9% | -$9M | — | $20M |
| 2023 | $24M | -$22M | 56.8% | -93.7% | -$14M | $10M | $23M |
| 2022 | $21M | -$16M | 65.8% | -79.5% | -$16M | $10M | $28M |
| 2021 | — | -$14M | — | — | -$13M | $10M | $54M |
| 2020 | — | -$7M | — | — | -$8M | $21M | $20M |
| 2019 | — | -$6M | — | — | -$3M | $2M | $6M |
| 2018 | — | -$6M | — | — | -$5M | $3M | $3M |
| 2017 | — | -$7M | — | — | -$6M | $5M | $9M |
| 2016 | — | -$8M | — | — | -$6M | $4M | $3M |
| 2015 | — | -$8M | — | — | — | $8M | $5M |
| 2014 | — | -$5M | — | — | -$7M | $11M | $9M |
| 2013 | — | -$7M | — | — | -$8M | — | $4M |
| 2012 | — | -$6M | — | — | -$8M | — | $2M |
| 2011 | — | -$8M | — | — | -$6M | — | $145478 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $12M | -$10M | 64.0% | -69.9% | -$9M | $50M | $36M |
| Dec '25 | $10M | -$8M | 61.5% | -67.7% | -$12M | $49M | $46M |
| Sep '25 | $9M | -$6M | 63.2% | -59.5% | -$3M | $29M | $38M |
| Jun '25 | $9M | -$6M | 60.3% | -61.6% | -$3M | $29M | $42M |
| Mar '25 | $8M | -$6M | 60.5% | -72.6% | -$6M | — | $12M |
| Dec '24 | $8M | -$5M | 61.3% | -72.5% | -$2M | — | $20M |
| Sep '24 | $8M | -$5M | 59.7% | -63.5% | -$1M | — | $22M |
| Jun '24 | $8M | -$4M | 63.5% | -60.1% | -$3M | $10M | $33M |
| Mar '24 | $8M | -$4M | 59.2% | -55.2% | -$4M | $10M | $35M |
| Dec '23 | $7M | -$5M | 58.9% | -69.1% | -$1M | $10M | $23M |
| Sep '23 | $6M | -$5M | 56.8% | -85.0% | -$2M | $10M | $24M |
| Jun '23 | $6M | -$7M | 52.5% | -119.8% | -$5M | $10M | $26M |
| Mar '23 | $5M | -$6M | 58.9% | -105.1% | -$6M | $10M | $22M |
| Dec '22 | $5M | -$4M | 65.1% | -86.4% | -$3M | $10M | $28M |
| Sep '22 | $5M | -$4M | 71.5% | -73.7% | -$4M | $10M | $19M |
| Jun '22 | $5M | -$4M | 62.6% | -80.8% | -$5M | $10M | $24M |
| Mar '22 | $5M | -$4M | 64.2% | -76.8% | -$4M | $10M | $50M |
| Dec '21 | — | -$4M | — | — | -$4M | $10M | $54M |
| Sep '21 | $5M | -$4M | 66.5% | -83.2% | -$3M | $18M | $58M |
| Jun '21 | — | -$4M | — | — | -$4M | $18M | $62M |
How the market has priced CLPT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, ClearPoint Neuro, Inc.'s revenue has grown 21.6% per year. These are computed facts, not advice.
As of FY2025, ClearPoint Neuro, Inc. reported $49M of total debt against $46M of cash; operating income covered interest expense -10.1×.
In FY2025, gross margin was 61.4%, operating margin -65.4%, and net margin -69.1%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.